Clinical Nurse Specialist Pathophysiology & Disease Management 2 — Questions and Answers
Question 1: A patient presents with a 3-day history of high fever, productive cough, and new RUL infiltrate. Blood cultures and sputum culture are sent. The CNS recognizes the clinical and radiographic presentation most consistent with community-acquired pneumonia (CAP). Which scoring tool best guides hospital admission vs. outpatient management decision?
- APACHE II score — ICU admission criteria for severe infections
- PSI (Pneumonia Severity Index) or CURB-65 score to stratify mortality risk and guide site-of-care decisions (Correct answer)
- SOFA score to assess organ dysfunction from pneumonia-related sepsis
- NEWS2 (National Early Warning Score) to detect clinical deterioration
Correct answer: PSI (Pneumonia Severity Index) or CURB-65 score to stratify mortality risk and guide site-of-care decisions
PSI (PORT score) and CURB-65 are validated CAP risk stratification tools that guide admission decisions — CURB-65 is simpler (5 criteria) and widely used in clinical practice.
CAP severity scoring for site-of-care decision: (1) CURB-65 (British Thoracic Society): C=confusion (new), U=urea >7 mmol/L (BUN >19 mg/dL), R=respiratory rate >=30/min, B=BP systolic <90 or diastolic <=60, 65=age >=65. Score 0-1: low risk, outpatient treatment; score 2: short inpatient admission; score >=3: severe, consider ICU. Simple, validated, widely adopted; (2) PSI (Pneumonia Severity Index/PORT score): 20 variables, 5 risk classes (I-V); Class I-II: outpatient; Class III: observation; Class IV-V: inpatient/ICU. More complex but validated in large cohort; (3) IDSA/ATS Minor criteria for ICU admission: >=3 of 9 minor criteria (hypoxemia, multilobar disease, uremia, leukopenia, thrombocytopenia, hypothermia, hypotension requiring fluids, RR >=30, PaO2/FiO2 <250) or >=1 major (mechanical ventilation, septic shock); (4) Typical organisms: S. pneumoniae (#1), H. influenzae, Legionella (atypical, high severity), Mycoplasma (young adults). Empiric treatment: beta-lactam + macrolide or respiratory fluoroquinolone per IDSA/ATS guidelines.
Question 2: A patient with lupus (SLE) develops progressive dyspnea and bilateral pleural effusions. Urinalysis shows 3+ protein and RBC casts. Complement C3 and C4 are markedly low. What pathophysiological process best explains the renal findings?
- Nephrotic syndrome from secondary amyloidosis in chronic SLE
- Lupus nephritis — immune complex deposition in glomeruli activates complement leading to inflammatory destruction of glomerular architecture (Correct answer)
- Drug-induced nephrotoxicity from hydroxychloroquine
- Hypertensive nephrosclerosis from chronic SLE-associated hypertension
Correct answer: Lupus nephritis — immune complex deposition in glomeruli activates complement leading to inflammatory destruction of glomerular architecture
RBC casts indicate glomerulonephritis; low complement levels and active SLE suggest lupus nephritis — immune complex deposition in glomeruli drives complement-mediated glomerular destruction.
Lupus nephritis (LN) pathophysiology: (1) SLE: loss of tolerance leads to autoantibodies (anti-dsDNA, anti-Smith, antiphospholipid) and immune complex formation; (2) Immune complex deposition in glomeruli: mesangial, subendothelial (proliferative classes III/IV), or subepithelial (membranous class V) locations trigger complement activation (classical pathway leading to C3a, C4a anaphylatoxins, C5b-9 MAC) and glomerular inflammation with proliferative nephritis; (3) Hypocomplementemia: immune complexes consume C3 and C4 — markers of active LN; anti-dsDNA levels correlate with disease activity; (4) ISN/RPS classification: Class I (minimal mesangial), Class II (mesangial proliferative), Class III (focal), Class IV (diffuse — most common, most severe), Class V (membranous — proteinuric), Class VI (advanced sclerosing); (5) Diagnosis: renal biopsy (gold standard); treatment: Class III/IV — induction with mycophenolate + hydroxychloroquine + glucocorticoids or cyclophosphamide; maintenance with mycophenolate or azathioprine + hydroxychloroquine. The CNS recognizes the nephritic syndrome (RBC casts, proteinuria) in the context of SLE activity markers.
Question 3: A 75-year-old patient with Parkinson's disease is admitted for aspiration pneumonia. The CNS reviews the pathophysiology of aspiration risk in Parkinson's disease. Which mechanism primarily contributes to aspiration risk?
- Autonomic dysfunction causing reduced saliva production and dry mouth
- Dopaminergic deficiency causing bradyphrenia and reduced cognitive function affecting swallowing decisions
- Impaired pharyngeal and laryngeal motor function due to dopaminergic deficiency and motor fluctuations (Correct answer)
- Tremor causing head movements that disrupt coordinated swallowing
Correct answer: Impaired pharyngeal and laryngeal motor function due to dopaminergic deficiency and motor fluctuations
Parkinson's disease causes impaired pharyngeal and laryngeal motility through dopaminergic deficiency, directly disrupting the complex motor coordination required for safe swallowing.
Dysphagia in Parkinson's disease (PD) pathophysiology: (1) Dopaminergic denervation of basal ganglia leads to bradykinesia and rigidity of swallowing musculature; (2) Oropharyngeal phase dysfunction: reduced bolus formation (lingual tremor, reduced lingual mobility), delayed swallow initiation, reduced pharyngeal contraction amplitude, incomplete UES (upper esophageal sphincter) relaxation, reduced laryngeal elevation and closure; (3) Silent aspiration: impaired laryngeal sensation leads to reduced cough reflex and aspiration without overt coughing — most dangerous aspect; (4) Esophageal involvement: esophageal dysmotility (PD affects enteric nervous system) plus gastroparesis contribute to additional aspiration risk; (5) Prevalence: 80-95% of PD patients have some dysphagia; aspiration pneumonia is the leading cause of death in advanced PD; (6) Assessment: VFSS (videofluoroscopic swallowing study) or FEES (fiberoptic endoscopic evaluation of swallowing); (7) Management: SLP evaluation, compensatory techniques (chin tuck, head rotation), diet modification (IDDSI framework), modified medication timing (before meals when ON), PEG consideration in advanced disease. The CNS coordinates the interprofessional dysphagia management team.
Question 4: A patient develops massive pulmonary embolism with hemodynamic instability (BP 80/50, HR 125, SpO2 82% on 15L NRB). Which pathophysiological cascade accounts for the hemodynamic instability?
- Pulmonary arterial vasodilation causing reduced SVR and systemic hypotension
- Acute right ventricular pressure overload leading to RV dilation and dysfunction, reduced LV filling, low cardiac output, and systemic hypotension (Correct answer)
- Left ventricular failure from clot migration across a patent foramen ovale
- Massive VTE causing distributive shock from systemic inflammatory response
Correct answer: Acute right ventricular pressure overload leading to RV dilation and dysfunction, reduced LV filling, low cardiac output, and systemic hypotension
Massive PE causes acute RV pressure overload — the RV dilates, interventricular septum shifts, LV filling is impaired (reduced preload), causing obstructive shock.
Massive PE hemodynamic cascade: (1) Large clot burden causes acute pulmonary arterial obstruction and acute rise in pulmonary vascular resistance (PVR); (2) Acute RV pressure overload: thin-walled RV (designed for low-pressure system) cannot acutely compensate for elevated PVR leading to RV dilation, wall tension increase, and RV ischemia (RCA compression by dilated RV, reduced coronary perfusion pressure); (3) Interventricular septal shift (D-sign on echo): dilated RV shifts septum leftward causing LV diastolic dysfunction and reduced LV filling; (4) Reduced LV preload leads to reduced LV stroke volume, reduced CO, systemic hypotension, and obstructive shock; (5) Hypoxemia: V/Q mismatch, intracardiac shunting (PFO opened by elevated RA pressure), low mixed venous PO2 from low CO; (6) Hemodynamic markers of massive PE: sustained hypotension (SBP <90 for >15 min or requiring vasopressors), cardiac arrest, profound shock; (7) Treatment: systemic thrombolysis (alteplase 100 mg IV over 2h) for massive PE with shock (unless absolute contraindications); catheter-directed thrombolysis for submassive; anticoagulation for all PE. Echo: RV/LV ratio >0.9, McConnell's sign (RV free wall hypokinesis with apical sparing), septal flattening.
Question 5: A 50-year-old patient with alcohol use disorder is admitted with jaundice, ascites, and spider angiomata. Laboratory findings: total bilirubin 8.5 mg/dL, albumin 2.1 g/dL, PT/INR 2.8, creatinine 0.9 mg/dL. Which pathophysiological mechanism explains the development of ascites in cirrhosis?
- Right heart failure causing hepatic congestion and transudative fluid accumulation
- Portal hypertension plus splanchnic vasodilation plus hypoalbuminemia leading to fluid transudation into the peritoneal cavity via Starling forces (Correct answer)
- Lymphatic obstruction from enlarged liver compressing thoracic duct
- Peritoneal inflammation from chronic alcohol-induced peritonitis
Correct answer: Portal hypertension plus splanchnic vasodilation plus hypoalbuminemia leading to fluid transudation into the peritoneal cavity via Starling forces
Cirrhotic ascites results from portal hypertension (increased hydrostatic pressure) combined with splanchnic vasodilation and hypoalbuminemia (reduced oncotic pressure) altering Starling forces.
Cirrhotic ascites pathophysiology — the 'overflow' and 'underfill' theories, now integrated: (1) Portal hypertension (sinusoidal, post-hepatic): cirrhotic fibrosis leads to increased intrahepatic resistance and elevated portal pressure; SAAG >=1.1 g/dL confirms portal hypertension as cause; (2) Splanchnic vasodilation: portal hypertension causes increased intestinal NO production and splanchnic arterial vasodilation leading to reduced effective arterial blood volume and RAAS activation causing Na+ and water retention and hypervolemia; (3) Hypoalbuminemia: impaired hepatic albumin synthesis leads to reduced plasma oncotic pressure and Starling forces that favor fluid extravasation; (4) Lymphatic overflow: hepatic lymph production exceeds thoracic duct capacity leading to weeping into peritoneum; (5) Combined Starling effect: increased splanchnic hydrostatic pressure + reduced oncotic pressure leads to peritoneal fluid accumulation; (6) Diagnosis: paracentesis for SAAG; PMN count >250/mm3 = SBP (spontaneous bacterial peritonitis); (7) Treatment: sodium restriction (<2g/day), spironolactone plus/minus furosemide (RAAS blockade), LVP (large volume paracentesis) with albumin replacement for tense ascites, TIPS for refractory ascites, transplant evaluation.
Question 6: A CNS is reviewing the pathophysiology of type 2 diabetes with a nursing team. Which sequence best describes the progressive pathophysiological mechanisms from normal glucose tolerance to established type 2 diabetes?
- Insulin resistance leading to pancreatic beta cell autoimmune destruction leading to absolute insulin deficiency and hyperglycemia
- Insulin resistance (muscle, liver, adipose) leading to compensatory hyperinsulinemia leading to progressive beta cell exhaustion leading to relative insulin deficiency and hyperglycemia (Correct answer)
- Glucagon excess leading to hepatic glucose overproduction leading to hyperglycemia and secondary insulin resistance
- Obesity leading to leptin deficiency leading to hypothalamic dysfunction and diabetes
Correct answer: Insulin resistance (muscle, liver, adipose) leading to compensatory hyperinsulinemia leading to progressive beta cell exhaustion leading to relative insulin deficiency and hyperglycemia
Type 2 DM progression: insulin resistance in peripheral tissues leads to compensatory pancreatic insulin overproduction, then gradual beta cell loss, then relative insulin deficiency, and clinical hyperglycemia.
Type 2 diabetes mellitus pathophysiology (Ominous Octet — DeFronzo): (1) Stage 1 — Insulin Resistance: skeletal muscle (most significant), liver, and adipose tissue develop reduced insulin sensitivity; mechanism: impaired GLUT4 translocation in muscle, increased hepatic gluconeogenesis, lipolysis; genetic factors plus obesity (excess FFA, adipokines, inflammation); (2) Stage 2 — Compensatory Hyperinsulinemia: pancreatic beta cells increase insulin secretion to overcome resistance and normal glucose is maintained; (3) Stage 3 — Beta Cell Exhaustion: chronic hyperstimulation leads to progressive beta cell dysfunction and apoptosis (glucotoxicity, lipotoxicity, amyloid deposition, oxidative stress); 50-80% of beta cell mass lost before T2DM diagnosis; (4) Stage 4 — Relative Insulin Deficiency: insulin secretion no longer sufficient to overcome resistance leading to fasting hyperglycemia and T2DM diagnosis; (5) Other contributors (DeFronzo's octet): increased glucagon secretion, increased renal glucose reabsorption (SGLT2), neurotransmitter dysfunction, incretin defect (reduced GLP-1 effect), increased hepatic glucose production. T2DM is not T1DM (which is autoimmune absolute insulin deficiency). The CNS educates teams on this progression to explain why early lifestyle intervention can halt or reverse progression.
Clinical Nurse Specialist Pathophysiology & Disease Management 2
A patient presents with a 3-day history of high fever, productive cough, and new RUL infiltrate.
Blood cultures and sputum culture are sent.
The CNS recognizes the clinical and radiographic presentation most consistent with community-acquired pneumonia (CAP).
Which scoring tool best guides hospital admission vs. outpatient management decision?